Clinical Trial Update: Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prolonged pulsatile kisspeptin administration for hypogonadotropic hypogonadism has completed, with an update on study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism

Drugs mentioned

• Kisspeptin-54 (Kisspeptin-54)

Snippet

Sponsor: Stephanie B. Seminara, MD | Conditions: Hypogonadotropic Hypogonadism | Phase 2 | Status: COMPLETED